Overview

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate T-20 in children.
Phase:
Phase 2
Details
Lead Sponsor:
Hoffmann-La Roche
Collaborator:
Trimeris
Treatments:
Enfuvirtide